Headline News about Cybin Inc
Cybin Announces FDA Approvals, Participation in Conference
December 01, 2021
Via Benzinga
Exposures
Product Safety
Cybin Inc. Receives Schedule I Manufacturing License from DEA
November 04, 2021
Via Benzinga
Cybin Reports Q2 Financial Results And Latest News, Including FDA & DEA Research Approvals
November 15, 2021
Via Benzinga
Exposures
Product Safety
Cybin: FDA Authorizes Feasibility Study To Measure Ketamine's Effect On Cerebral Cortex
October 27, 2021
Via Benzinga
Exposures
Product Safety
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|